Escapharm SPRL
The score of Escapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +53 % Total assets +28 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Escapharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 119,392 € | ||||
| Equity | 821,186 € | ||||
| Cash | 32,849 € | ||||
| EBITDA | 225,565 € | ||||
| Total assets | €1.46m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Aug 2026
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Escapharm's financial analysis
- Solvency56.4%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Escapharm
Escapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0897.206.151
- VAT number
- BE0897206151
- Peppol
- Registered · 0208:0897206151 · as of 05 Nov 2026
- Legal form
- SPRL
- Incorporated
- 08 Apr 2008
- Registered office
- 9690 Kluisbergen
- Latest accounts
- 2025 · filed on 13 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Escapharm (SPRL) has been based in Kluisbergen since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 119,392 € and equity of 821,186 €; its revenue is not published. Its solvency stands at 56.4%, above the median of its sector (44.0%).
Companies similar to Escapharm
Companies in the same business, of comparable size and area, outside its group.
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apolex Retail sale of pharmaceutical products Wichelen · balance sheet €1.47m
- Verbifarma Retail sale of pharmaceutical products Pittem · balance sheet €1.47m
- Apotheek DE Wilde ZEE Retail sale of pharmaceutical products Antwerp · balance sheet €1.48m
- Vanschoonbeek Farma Retail sale of pharmaceutical products Bekkevoort · balance sheet €1.50m
- Dieusaert Pharma Retail sale of pharmaceutical products Heuvelland · balance sheet €1.41m
Frequently asked questions about Escapharm
What is the revenue of Escapharm?
Escapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Escapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0897206151 for Escapharm, if the company is VAT-registered. Its company number (CBE) is 0897.206.151.
Where is the registered office of Escapharm?
According to the CBE register, the registered office of Escapharm is in 9690 Kluisbergen.
What is the equity of Escapharm?
At the close of the 2025 financial year, the equity of Escapharm amounts to 821,186 €, a solvency of 56.4% of total assets.
Who manages Escapharm?
The register lists 2 active mandates at Escapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Escapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →